Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer

Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency

(2019) Olga Kutova et al.   Cancers

Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer

(2019) Fan Lei et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study

(2019) Antonella Argentiero et al.   Cancers

Sequence modification of heptapeptide selected by phage display as homing device for HT-29 colon cancer cells to improve the anti-tumour activity of drug delivery systems

(2019) Krisztina Kiss et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice

(2019) Ranđelović et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma Cells

(2019) Lajkó et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site

(2018) Eirinaios I Vrettos et al.   Beilstein Journal of Organic Chemistry

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Challenges in diagnosis of pancreatic cancer

(2018) Lulu Zhang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Ferrocene-Containing Impiridone (ONC201) Hybrids: Synthesis, DFT Modelling, In Vitro Evaluation, and Structure–Activity Relationships

(2018) Péter Bárány et al.   MOLECULES

Pharmacotherapeutic strategies for treating pancreatic cancer: advances and challenges

(2018) Maria Diab et al.   EXPERT OPINION ON PHARMACOTHERAPY

Small molecule-drug conjugates: A novel strategy for cancer-targeted treatment

(2018) Chunlin Zhuang et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

NGR-peptide−drug conjugates with dual targeting properties

(2017) Kata Nóra Enyedi et al.   PLoS One

Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells

(2016) Vanna Sanna et al.   JOURNAL OF MEDICINAL CHEMISTRY

MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway

(2015) Wei Zhou et al.   Oncotarget

Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH analog AEZS-108

(2015) Karoly Szepeshazi et al.   Oncotarget

Peptide Conjugation: Before or After Nanoparticle Formation?

(2014) Sabrina Valetti et al.   BIOCONJUGATE CHEMISTRY

Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor

(2014) Sabrina Valetti et al.   JOURNAL OF CONTROLLED RELEASE

The role of senescent cells in ageing

(2014) Jan M. van Deursen   NATURE

LGR5 Interacts and Cointernalizes with Wnt Receptors To Modulate Wnt/ -Catenin Signaling

(2012) K. S. Carmon et al.   MOLECULAR AND CELLULAR BIOLOGY

Development of Peritoneal Tumor-Targeting Vector by In Vivo Screening with a Random Peptide-Displaying Adenovirus Library

(2012) Takeshi Nishimoto et al.   PLoS One

Enhanced Enzymatic Stability and Antitumor Activity of Daunorubicin-GnRH-III Bioconjugates Modified in Position 4

(2011) Marilena Manea et al.   BIOCONJUGATE CHEMISTRY

Pancreatic cancer

(2011) Audrey Vincent et al.   LANCET

In vitro degradation and antitumor activity of oxime bond-linked daunorubicin–GnRH-III bioconjugates and DNA-binding properties of daunorubicin–amino acid metabolites

(2010) Erika Orbán et al.   AMINO ACIDS

Pancreatic Cancer

(2010) Manuel Hidalgo   NEW ENGLAND JOURNAL OF MEDICINE

Development of an Oxime Bond Containing Daunorubicin-Gonadotropin-Releasing Hormone-III Conjugate as a Potential Anticancer Drug

(2009) Ildikó Szabó et al.   BIOCONJUGATE CHEMISTRY